Concepedia

Publication | Open Access

Ramucirumab Plus Pembrolizumab in Patients with Previously Treated Advanced or Metastatic Biliary Tract Cancer: Nonrandomized, Open-Label, Phase I Trial (JVDF)

DOIFull Paper Access

166

Citations

28

References

2018

Year

Hendrik‐Tobias Arkenau, Juan Martín-Liberal, Emiliano Calvo, Nicolas Penel, Matthew Krebs, Roy S. Herbst, Richard A. Walgren, Ryan C. Widau, Gu Mi, Jin Jin,
The Oncologist

Abstract

Ramucirumab<b>-</b>pembrolizumab showed limited clinical activity with infrequent grade 3-4 TRAEs in patients with biomarker-unselected progressive BTC.

References

YearCitations

Page 1